| |
| |
|
| Insider
Information: |
Deerfield Partners, Lp |
| Relationship: |
* Director by Deputiza... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
26 |
|
| Direct
Shares |
650,000 |
|
|
Indirect Shares
|
48,612,824 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$443,341,143 |
|
|
| Total
Shares |
49,262,824 |
|
|
| Total
Value |
$443,341,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -37.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fischer Imaging Corp |
FIMG |
10% Owner |
2005-09-28 |
0 |
2005-09-28 |
0 |
Premium* |
|
|
Arena Pharmaceuticals Inc |
ARNA |
10% Owner |
2007-10-19 |
0 |
2007-10-19 |
3,238,908 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Possible Member of 10%... |
2014-12-23 |
0 |
2014-12-23 |
2,793,072 |
Premium* |
|
|
Ehealth, Inc. |
EHTH |
Possible Member of 10%... |
2015-01-14 |
0 |
2015-01-14 |
1,804,903 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
Possible Member of 10%... |
2015-09-22 |
0 |
2015-09-22 |
49,000 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Possible Member of 10%... |
2018-03-06 |
0 |
2018-03-08 |
305,965 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
*Possible member of 10... |
2018-05-09 |
0 |
2018-05-09 |
8,308,455 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
*Possible member of 10... |
2018-05-29 |
0 |
2018-05-29 |
843,352 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2019-05-09 |
0 |
2019-06-27 |
3,159,165 |
Premium* |
|
|
Korro Bio |
KRRO |
Possible Member of 10%... |
2019-10-07 |
0 |
2019-10-07 |
285,714 |
Premium* |
|
|
Cabaletta Bio, Inc. |
CABA |
Possible Member of 10%... |
2019-10-29 |
0 |
2019-10-29 |
700,000 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
Possible Member of 10%... |
2020-02-03 |
0 |
2020-02-03 |
778,790 |
Premium* |
|
|
Schrodinger, Inc. |
SDGR |
Possible Member of 10%... |
2020-02-10 |
0 |
2020-02-10 |
250,000 |
Premium* |
|
|
Revolution Medicines, Inc. |
RVMD |
Possible Member of 10%... |
2020-02-18 |
0 |
2020-02-18 |
798,795 |
Premium* |
|
|
Oncology Institute |
TOIIW |
Director by Deputizati... |
2020-03-13 |
0 |
2020-03-13 |
2,500,000 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
Possible Member of 10%... |
2020-06-16 |
0 |
2020-06-16 |
1,186,215 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
Possible Member of 10%... |
2020-07-14 |
0 |
2020-07-14 |
1,209,936 |
Premium* |
|
|
Caremax Class A |
CMAX |
Director by Deputizati... |
2020-07-21 |
0 |
2021-06-08 |
50,000 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
Possible Member of 10%... |
2020-07-28 |
0 |
2020-07-28 |
808,914 |
Premium* |
|
|
Acutus Medical, Inc. |
AFIB |
Director by Deputizati... |
2020-08-05 |
0 |
2021-07-19 |
3,440,811 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
*Possible Member of 10... |
2020-09-29 |
0 |
2020-09-29 |
1,853,967 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
Possible Member of 10%... |
2021-05-04 |
0 |
2021-05-04 |
2,552,787 |
Premium* |
|
|
Nuvalent, Inc. |
NUVL |
Director, 10% Owner |
2022-11-03 |
650,000 |
|
0 |
Premium* |
|
|
Frazier Lifesciences Acquisition... |
FLAC |
10% Owner |
|
0 |
2022-11-08 |
2,480,199 |
Premium* |
|
|
Oncorus, Inc. |
ONCR |
Possible Member of 10%... |
2022-12-13 |
0 |
2022-12-30 |
284,697 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
* Director by Deputiza... |
2024-02-16 |
0 |
2024-02-16 |
8,929,179 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LRMR |
Larimar Therapeutics Inc |
* Director by Deputization |
– • • |
2024-02-16 |
4 |
B |
$8.74 |
$37,499,993 |
I/I |
4,290,617 |
4,207,982 |
2.25 |
- |
|
| ONCR |
Oncorus, Inc. |
Possible Member of 10% Group |
– – • |
2022-12-30 |
4 |
S |
$0.27 |
$37,495 |
I/I |
(138,872) |
284,697 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
Possible Member of 10% Group |
– – • |
2022-12-29 |
4 |
S |
$0.26 |
$36,856 |
I/I |
(141,753) |
299,917 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
Possible Member of 10% Group |
– – • |
2022-12-28 |
4 |
S |
$0.25 |
$13,903 |
I/I |
(55,610) |
315,455 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
Possible Member of 10% Group |
– – • |
2022-12-27 |
4 |
S |
$0.27 |
$17,574 |
I/I |
(65,090) |
321,551 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
Possible Member of 10% Group |
– – • |
2022-12-22 |
4 |
S |
$0.28 |
$2,322 |
I/I |
(8,294) |
328,687 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-21 |
4 |
S |
$0.30 |
$4,140 |
I/I |
(13,800) |
329,596 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-20 |
4 |
S |
$0.31 |
$4,569 |
I/I |
(14,740) |
331,109 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-19 |
4 |
S |
$0.29 |
$28,918 |
I/I |
(99,718) |
332,725 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-15 |
4 |
S |
$0.39 |
$1,205 |
I/I |
(3,089) |
343,655 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-14 |
4 |
S |
$0.38 |
$3,268 |
I/I |
(8,600) |
343,994 |
0 |
- |
|
| ONCR |
Oncorus, Inc. |
*Possible Member of 10% Group |
– – • |
2022-12-13 |
4 |
S |
$0.41 |
$860 |
I/I |
(2,097) |
344,937 |
0 |
- |
|
| FLAC |
Frazier Lifesciences Acqu... |
10% Owner |
– – • |
2022-11-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,480,199 |
|
- |
|
| NUVL |
Nuvalent, Inc. |
Director |
– • • |
2022-11-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
650,000 |
|
- |
|
| AFIB |
Acutus Medical, Inc. |
Director by Deputization |
– • • |
2021-07-19 |
4 |
B |
$14.00 |
$14,999,992 |
I/I |
1,071,428 |
3,438,589 |
2.25 |
- |
|
| CMAX |
Caremax Class A |
Director by Deputization |
– • • |
2021-06-08 |
4 |
A |
$10.00 |
$100,000,000 |
I/I |
10,000,000 |
400,000 |
0 |
- |
|
| CMAX |
Caremax Class A |
Director by Deputization |
– • • |
2021-06-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,418,750 |
50,000 |
0 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
Possible Member of 10% Group |
– – • |
2021-05-04 |
4 |
B |
$16.00 |
$12,800,000 |
I/I |
800,000 |
2,552,787 |
1.5 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
Possible Member of 10% Group |
– – • |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,752,787 |
1,752,787 |
0 |
- |
|
| CALC |
Calcimedica Ord Shs |
*Possible Member of 10% Group |
– – • |
2020-09-29 |
4 |
B |
$16.00 |
$25,000,000 |
I/I |
1,562,500 |
1,853,967 |
1.5 |
% |
|
| CALC |
Calcimedica Ord Shs |
*Possible Member of 10% Group |
– – • |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,719,213 |
291,467 |
0 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director by Deputization |
– • • |
2020-08-10 |
4 |
B |
$18.00 |
$27,000,000 |
I/I |
1,500,000 |
2,758,000 |
2.25 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director by Deputization |
– • • |
2020-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,841,802 |
2,202,444 |
0 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director by Deputization |
– • • |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,222 |
2,222 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
Possible Member of 10% Group |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
917,828 |
458,914 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
